The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 29, 2025

Filed:

Dec. 20, 2021
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Jason Mastaitis, Yorktown Heights, NY (US);

Andrew J. Murphy, Croton-on-Hudson, NY (US);

John Mcwhirter, Savannah, GA (US);

Vera Voronina, North Bethesda, MD (US);

Jesper Gromada, Concord, MA (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); A01K 67/0275 (2024.01); C07K 14/58 (2006.01); C07K 14/72 (2006.01); C07K 16/26 (2006.01); C12N 9/22 (2006.01); C12N 15/11 (2006.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
C07K 16/00 (2013.01); A01K 67/0275 (2013.01); C07K 14/58 (2013.01); C07K 14/72 (2013.01); C07K 16/26 (2013.01); C12N 9/22 (2013.01); C12N 15/11 (2013.01); C12N 15/907 (2013.01); A01K 2217/07 (2013.01); A01K 2227/105 (2013.01); A01K 2267/01 (2013.01); C07K 2317/56 (2013.01); C07K 2317/76 (2013.01); C12N 2310/20 (2017.05);
Abstract

Described herein are anchor-modified immunoglobulin polypeptides, wherein the anchor moors the immunoglobulin polypeptide to a receptor of interest. The anchor-modified immunoglobulin polypeptides are generally characterized at the N-terminus with an anchor, e.g., the receptor binding portion of a ligand that binds a receptor. Non-human animals genetically modified with recombinant immunoglobulin segments that encode the anchor-modified immunoglobulin polypeptides are capable of making the anchor-modified immunoglobulin polypeptides. Such non-human animals also provided, along with methods and compositions for making and using the non-human animals. Methods for producing anchor-modified immunoglobulins from non-human animals are also provided, as well as anchor-modified immunoglobulins generated therefrom.


Find Patent Forward Citations

Loading…